Company Announcement BioPorto adopts new rapid route to wi

Successful product development means that BioPorto is now focusing on a new type of NGAL test. The test is designed for use in a wide range of the fully automated systems that are already in use for the vast majority of the millions of tests that are performed every day in hospitals all over the wor..